PHAT Key Financial Ratios - Phathom Pharmaceuticals, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	1.92	-0.48	-30.29%	28.78%
2026-03-31	2.21	-0.49	-51.55%	46.68%
2025-12-31	1.73	-0.48	-85.37%	50.49%
2025-09-30	2.23	-0.49	-114.26%	64.98%
2025-06-30	2.38	-0.51	-131.95%	81.35%
2025-03-31	3.58	-0.6	-117.53%	102.19%
2024-12-31	4.2	-0.79	-88.37%	131.84%
2024-09-30	5.73	-0.94	-87.70%	181.41%
2024-06-30	6.48	-0.75	-93.03%	127.06%
2024-03-31	7.83	-1	-69.18%	166.08%
2023-12-31	10.25	-1.89	-48.71%	277.07%
2023-09-30	9.46	—	-74.72%	996.28%
2023-06-30	11.96	—	-69.77%	-1050.66%
2023-03-31	9.68	—	-135.32%	216.06%
2022-12-31	6.12	-1.27	-119.97%	264.29%
2022-09-30	8.65	—	-88.40%	675.56%
2022-06-30	9.93	—	-76.85%	2343.90%
2022-03-31	12.79	—	-100.44%	-393.60%
2021-12-31	9.86	—	-75.96%	-199.41%
2021-09-30	8.1	—	-70.84%	-156.34%
2021-06-30	5.34	0.36	-74.20%	-120.51%
2021-03-31	5.94	0.29	-58.36%	-87.48%
2020-12-31	5.25	0.24	-43.74%	-66.44%
2020-09-30	8.21	0.3	-75.08%	-110.85%
2020-06-30	18.76	0.25	-82.15%	-110.05%
2020-03-31	57.22	—	-103.83%	-131.30%
2019-12-31	68.2	—	-99.20%	-111.92%
2019-09-30	0.37	—	-197.74%	103.38%
2019-06-30	—	—	—	106.40%
2019-03-31	—	—	—	90.07%
2018-12-31	0.41	—	-142.79%	100.16%

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	1.73	-0.48	-85.37%	50.49%
2024-12-31	4.2	-0.79	-88.37%	131.84%
2023-12-31	10.25	-1.89	-48.71%	277.07%
2022-12-31	6.12	-1.27	-119.97%	264.29%
2021-12-31	9.86	—	-75.96%	-199.41%
2020-12-31	5.25	0.24	-43.74%	-66.44%
2019-12-31	68.2	—	-99.20%	-111.92%
2018-12-31	0.41	—	-142.79%	100.16%